The appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Companys product and partnership programs.
Tilos marks the first island to achieve 100% diversion from landfill with an 87% recycling rate.
Inflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
This year’s Veeva R&D and Quality Summit in Madrid, accentuated the current trends and needs of the pharma and life sciences industries.
Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals Inc.
BioSenic SA has suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell therapy ALLOB.
Swedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders.
An international research team headed by Pablo Guardado-Calvo at Institut Pasteur Paris has demonstrated evaluated antibody efficacy against lethal hantaviruses.
The new Krakow headquarters of preclinical CRO Selvita have opened.
3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its international expansion with the opening of its first commercial office in the United States located in Boston, Massachusetts.